Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.

In vivo models of acquired resistance to the platinum-based agents cisplatin (CDDP), carboplatin (CBDCA), iproplatin (CHIP) and tetraplatin have been established using a panel of six parent human ovarian carcinoma lines, two (HX/110 and PXN/87) being derived from previously untreated patients. Resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, M., Siracky, J., Kelland, L. R., Harrap, K. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968234/
https://www.ncbi.nlm.nih.gov/pubmed/8427780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968234/
https://www.ncbi.nlm.nih.gov/pubmed/8427780

Ejemplares similares